Medicine stands for "lagging behind"? How to improve the core competitiveness in the future

[pharmaceutical network market analysis] it is understood that in recent years, due to the impact of the epidemic, many hospitals' outpatient clinics have been temporarily closed, and pharmaceutical representatives are facing a more awkward situation In view of the situation that many medical representatives may not be able to enter the hospital in the next few months, there has been a heated discussion in the industry recently It is believed that the inability of medical representatives to enter the hospital within a few months will bring cost burden to some companies, especially some small and medium-sized enterprises, which are currently facing great cost pressure However, some pharmaceutical representatives pointed out that not all pharmaceutical representatives would "drag their feet" and increase the burden of the company As in the past, some novel coronavirus related products have been pushed ahead to the market, and some home office drugs have been playing a role in promoting academic concepts and new products, as has been done for some time Q1 A lot of people are concerned about whether medical representatives will be needed in the future? Industry insiders said that due to the influence of policies such as volume purchasing, drug prices have become a trend In the case of the middle link being squeezed, many pharmaceutical companies have included the representatives of drugs whose costs have been seriously reduced in the layoff team For example, in the expansion of centralized mining, Beijing Jialin Pharmaceutical Co., Ltd., which failed to win the bid, soon announced the dissolution of the sales team; Sanofi, a multinational pharmaceutical company, optimized the diversion of the medical team and sales team of Plavix It is estimated that half of the current two million drug generations will be eliminated in the next five years or so It can be seen that the operational space of pharmaceutical representatives is indeed getting smaller, but in fact, many pharmaceutical enterprises still need to use pharmaceutical representatives for academic promotion of products According to the industry, even for generic drugs, in addition to large varieties winning the bid with volume procurement, a small number of generic drugs in some subdivisions still need to learn and tap Therefore, in the future, medical representatives will not disappear, but return to the standard So how can the core competitiveness of the medical representatives who remain in their posts in the next five years be improved? Some people in the industry have expressed some opinions The author summarizes the following aspects First, do basic "homework" Medical representatives need to deeply understand the new progress of disease treatment, clinical difficulties and pain points, on this basis, comb out the advantages and competitive opportunities of products Second, keep pace with the times Pharmaceutical representatives need to motivate themselves to learn and improve their ability to provide valuable professional services for customers Third, improve the initiative and be the professional assistant of customers For example, there are many clinical research projects in the hands of customers, but there are some inconveniences Medical representatives can help customers to do some follow-up and data sorting work within their capabilities online, and help customers to do a good job of patient education online, including live broadcast, online Q & A, etc Fourth, improve professional quality On the basis of the above three points, the medical representatives need to be able to add points in professional quality and moral character, and more appreciated by customers In addition, the industry believes that the formulation of product promotion strategies for specific customers will be an important work for pharmaceutical representatives, which needs to be taken seriously In general, pharmaceutical representatives will inevitably face adjustment and simplification In the future, they will not only face higher requirements in financial standards, academic promotion, education and comprehensive quality, but also need to have good customer relations and strong business service and management capabilities Pharmaceutical representatives will face a "big test"